STRATA Skin Sciences (SSKN) Asset Writedowns and Impairment (2013 - 2025)
STRATA Skin Sciences' (SSKN) quarterly Asset Writedowns and Impairment came in at -$166000.0 in Q3 2025, up 8.29% year-on-year from -$153295.9 in Q3 2024, and down 200.0% quarter-over-quarter from $166000.0 in Q2 2025.
STRATA Skin Sciences (SSKN) Asset Writedowns and Impairment (2013 - 2025) Analysis & Trends
STRATA Skin Sciences has disclosed Asset Writedowns and Impairment across 13 years of filings, most recently posting -$166000.0 for Q3 2025.
- Asset Writedowns and Impairment for Q3 2025 came in at -$166000.0, up 8.29% year-over-year; the trailing twelve-month figure through Sep 2025 was -$142000.0 (down 186.06% YoY), and the FY2024 annual result was -$182000.0, changed N/A from the prior year.
- Asset Writedowns and Impairment came in at -$166000.0 for Q3 2025 at STRATA Skin Sciences, down from $166000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $205000.0 in Q4 2023 to a low of -$181000.0 in Q3 2024.
- The 5-year median for Asset Writedowns and Impairment is -$14000.0 (2021), against an average of -$4352.9.
- Peak annual rise in Asset Writedowns and Impairment reached 700.0% in 2021, while the deepest fall reached 2800.0% in 2021.
- STRATA Skin Sciences' Asset Writedowns and Impairment stood at $27000.0 in 2021, then jumped by 207.41% to $83000.0 in 2022, then jumped by 146.99% to $205000.0 in 2023, then tumbled by 169.27% to -$142000.0 in 2024, then decreased by 16.9% to -$166000.0 in 2025.
- The last three Asset Writedowns and Impairment figures came in at -$166000.0 (Q3 2025), $166000.0 (Q2 2025), and -$142000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | STRATA Skin Sciences | - | - | 5.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -166,000.00 |
| Sep 30, 2025 | -166,000.00 |
| Jun 30, 2025 | 166,000.00 |
| Jun 30, 2025 | 166,000.00 |
| Dec 31, 2024 | -142,000.00 |
| Dec 31, 2024 | -142,000.00 |
| Sep 30, 2024 | -181,000.00 |
| Sep 30, 2024 | -181,000.00 |
| Mar 31, 2024 | 141,000.00 |
| Mar 31, 2024 | 141,000.00 |
| Dec 31, 2023 | 205,000.00 |
| Dec 31, 2023 | 205,000.00 |
| Sep 30, 2023 | -67,000.00 |
| Sep 30, 2023 | -67,000.00 |
| Jun 30, 2023 | -43,000.00 |
| Jun 30, 2023 | -43,000.00 |
| Mar 31, 2023 | -95,000.00 |
| Mar 31, 2023 | -95,000.00 |
| Dec 31, 2022 | 83,000.00 |
| Dec 31, 2022 | 83,000.00 |